BIOMAT Database Logo BIOMAT Database Logo

Design and synthesis of conformationally constrained inhibitors of non-nucleoside reverse transcriptase. 2011

Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Departments of West Point Discovery Chemistry, Pennsylvania 19486-0004, United States. Robert_gomez@merck.com

Highly active antiretroviral therapy (HAART) significantly reduces human immunodeficiency virus (HIV) viral load and has led to a dramatic decrease in acquired immunodeficiency syndrome (AIDS) related mortality. Despite this success, there remains a critical need for new HIV therapies to address the emergence of drug resistant viral strains. Next generation NNRTIs are sought that are effective against these mutant forms of the HIV virus. The bound conformations of our lead inhibitors, MK-1107 (1) and MK-4965 (2), were divergent about the oxymethylene linker, and each of these conformations was rigidified using two isomeric cyclic constraints. The constraint derived from the bioactive conformation of 2provided novel, highly potent NNRTIs that possess broad spectrum antiviral activity and good pharmacokinetic profiles. Systematic SAR led to the identification of indazole as the optimal conformational constraint to provide MK-6186 (3) and MK-7445 (6). Despite their reduced flexibility, these compounds had potency comparable to that of the corresponding acyclic ethers in both recombinant enzyme and cell based assays against both the wild-type and the clinically relevant mutant strains.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D009578 Nitrobenzenes BENZENE derivatives carrying nitro group substituents.
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell

Related Publications

Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
[Non-nucleoside reverse transcriptase inhibitors].
June 2000, Annales de medecine interne,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Non-nucleoside reverse transcriptase inhibitors.
June 1996, BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Design and synthesis of conformationally-constrained MMP inhibitors.
August 1998, Bioorganic & medicinal chemistry letters,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Design, synthesis and biological evaluation of a series of thioamides as non-nucleoside reverse transcriptase inhibitors.
November 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
June 2008, Journal of HIV therapy,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Non-nucleoside reverse transcriptase inhibitors: a review.
January 2007, International journal of clinical practice,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Non-nucleoside reverse transcriptase inhibitors--an overview.
February 2003, International journal of STD & AIDS,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
[Resistance to non-nucleoside reverse transcriptase inhibitors].
February 2001, Enfermedades infecciosas y microbiologia clinica,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Design, synthesis, anti-HIV activities, and metabolic stabilities of alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors.
June 2004, Journal of medicinal chemistry,
Robert Gomez, and Samson J Jolly, and Theresa Williams, and Joseph P Vacca, and Maricel Torrent, and Georgia McGaughey, and Ming-Tain Lai, and Peter Felock, and Vandna Munshi, and Daniel Distefano, and Jessica Flynn, and Mike Miller, and Youwei Yan, and John Reid, and Rosa Sanchez, and Yuexia Liang, and Brenda Paton, and Bang-Lin Wan, and Neville Anthony
Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
August 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!